NCT03367247 2026-03-10BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and RenewalDana-Farber Cancer InstitutePhase NA Completed121 enrolled 16 charts
NCT00326885 2018-10-17Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant AscitesNeovii BiotechPhase 2 Completed32 enrolled 12 charts
NCT00327444 2013-01-01Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant AscitesSanofiPhase 2/3 Completed58 enrolled 11 charts